Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Military Seeks Decon Lotion for Chemical Warfare Agents

by Global Biodefense Staff
February 14, 2013

Reactive Skin Decontamination LotionThe Defense Logistics Agency (DLA) – Troop Support is seeking information from sources capable of providing Skin Decontamination Lotion, intended to remove or neutralize chemical warfare agents HD, Soman (GD), VX and T-2 toxin from the skin. 

The Decontamination Lotion is required to be pre-packaged on a sponge applicator pad individually sealed in a polyethylene-lined aluminum foil pouch. The foil pouch must be easy for military personnel to open while wearing chemical warfare protective clothing and gloves. U.S. Food and Drug Administration (FDA) for application on unbroken skin of hands, face, neck, limbs, and torso. The manufacturer shall also provide a training lotion that imitates the properties of the decontamination lotion in all but active decontaminating ingredients.

DLA has estimated annual requirements between 720,000 and 1,260,000 packets of lotion for the next 5 years. Ordered quantities will be delivered to military ordering activities or Defense depots located throughout the United States. The government is will guarantee a minimum purchase of 252,000 packets per year. 

Organizations that currently develop or manufacture this type of product are invited to submit information to DLA Troop Support to help inform a future request for proposal.

Further details are available under FBO Solicitation Number: SPM2DP11R0103. The response deadline is April 29, 2013. 

Image source: First Line Technology

Tags: RFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy